Project

Confirming the applicability of the anti-EGFR Nanobodies for fluorescence-guided surgery in canine and human head and neck cancer

Code
365D05621
Duration
01 December 2021 → 30 November 2024
Funding
Funding by bilateral agreement (private and foundations)
Research disciplines
  • Medical and health sciences
    • Diagnostics not elsewhere classified
    • Cancer therapy
Keywords
nanobodies fluorescence-guided surgery solid tumors EGFR
 
Project description
No data available